RESULTS OF TREATMENT MANAGEMENT OF RIFAMPICIN-RESISTANT TUBERCULOSIS IN THAI NGUYEN PERIOD 2016-2020 AND SOME RELATED FACTORS

Đào Thị Hương, Hoàng Hà, Trần Thế Hoàng

Main Article Content

Abstract

Objectives: To describe the results of treatment management of rifampicin-resistant tuberculosis in Thai Nguyen period 2016-2020 and some related factors. Research Method: A cross-sectional descriptive study was conducted on 92 rifampicin-resistant patients in the period 2016-2020 at Thai Nguyen Tuberculosis and Lung Disease Hospital. Results: The mean age of rifampicin-resistant patients was 40.9±12.3, the male proportion was 79.3%. The proportion of TB retreatment was 73.9%, new cases 26.1% and HIV(+) 19.6%. The proportion of lung TB was 97.8%; AFB(+) 72.8%. The proportion of testing adherence during treatment follow-up was 28.3%. The proportion of cure 3.5%, treatment completed 75.5%, death 10.5%, failure 2.3%, dropout 7.0%, transferred out 1.2%. There were relationship between: poor household economic status, TB retreatment, comorbidities, HIV(+), AFB(+), 20 months treatment duration, patients in prison, non-testing adherence and had adverse drug reaction with unsuccessful treatment of rifampicin-resistant (p<0.05). Conclusion: The proportion of RR-TB successful treatment in Thai Nguyen is relatively high, the retreatment and disease characteristics factors are related to unsuccessful treatment.

Article Details

References

1. Chương trình chống lao quốc gia (2021), Báo cáo tổng kết chương trình chống lao năm 2020, Bộ Y tế, Hà Nội.
2. Bộ Y tế (2020), Cập nhật hướng dẫn chẩn đoán điều trị và dự phòng bệnh lao, Nhà xuất bản Y học, Hà Nội.
3. Bulabula A.N.H., Nelson J.A., Musafiri E.M., et al. (2019), "Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study", Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 69 (8), pp. 1278-1287.
4. Katende B., Esterhuizen T.M., Dippenaar A., et al. (2020), "Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes", Sci Rep, 10 (1), pp. 1917.
5. Phuong N.T.M., Nhung N.V., Hoa N.B., et al. (2016), "Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam", Public health action, 6 (1), pp. 25-31.
6. Van Le Hong, Phu Phan Trieu, Vinh Dao Nguyen, et al. (2020), "Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study", BMC Infectious Diseases, 20 (1), pp. 164.
7. World Health Organization (2020), Global tuberculosis report 2020, World Health Organization, Geneva, Switzerland.